December 2, 2011
Dainippon Sumitomo Pharma (DSP), Mitsubishi Tanabe Pharma Corporation (MTPC), and its consolidated subsidiary Yoshitomiyakuhin Corporation announced on December 1 that DSP and Yoshitomiyakuhin will terminate a copromotion agreement between them for DSP’s atypical antipsychotics Lonasen (blonanserin) and Lullan (perospirone HCL)...read more